ClinicalTrials.govpublic full text
Use Lenalidomide (Revlimid®) in Combination With Dexamethasone in Clinical Practice for the Treatment of Newly Diagnosed Multiple Myeloma (MM) Transplant Ineligible Patients
multiple myeloma, revlimid, lenalidomide, non-transplantable, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1009571
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.